EA Series Trust Militia Long/Short Equity ETF ORR 深 沪

Nanobiotix-J&J Therapy Shows Promise In Tough Head And Neck Cancer

Nanobiotix reported updated Phase 1 trial data for JNJ-1900 in head and neck cancer, showing strong disease control and survival outcomes.

10-01 01:43

Orion Group Holdings Announces the Appointment of Robert Ledford to its Board of Directors

Orion Group Holdings, Inc. announced the appointment of Robert (Bob) Ledford to its Board of Directors effective November 19, 2025. Travis Boone, President and CEO, highlighted Ledford's extensive leadership in construction and engineering, financial expertise, and track record in driving growth through mergers and acquisitions. Ledford brings over 35 years of experience, including roles at Prime Electric and AECOM. He will join Orion's Board, ex...

09-29 12:57

韩国时尚品牌ORR进驻中国上海Réel百货

09-26 17:06

肿瘤耐药治疗赛道破局者：应世生物赴港IPO

在创新药投资的淘金浪潮中，真正值得长期押注的，永远是那些能够定义赛道、并拥有清晰商业化路径的破局者。 当行业从概念炒作回归价值本质，一家聚焦肿瘤耐药这一核心难题...

09-26 09:36

艾伯维(ABBV.US)旗下艾可瑞妥单抗在华申报新适应症

9月23日，药品审评中心(CDE)网站显示，艾伯维(ABBV.US)的艾可瑞妥单抗注射液(epcoritamab)在华申报新适应症。

09-24 14:40

FDA Clears Merck's One-Minute Cancer Shot

FDA approves Merck's Keytruda Qlex injection for adults with solid tumors. Merck expects it to be available in the U.S. in September.

09-23 01:23

康诺亚-B盘中涨超5% 旗下首款双抗药物CM336启动III期研究

康诺亚-B（02162）盘中涨超5%，截至发稿，股价上涨3.75%，现报74.80港元，成交额8907.02万港元。 　　据医药魔方Info报道，9月18日，全...

09-22 10:25

探索价值投资在创新药领域的深度适配与融合 | 巴伦精选

2025年7月份，东方马拉松团队非常荣幸在百年财经Barron's巴伦中文网发表过《探究争论不休的世纪话题：科技公司与价值投资如何适配融合？》一文，探讨了价值投...

09-21 09:32

Merck's Keytruda Gets Green Light For New Head And Neck Cancer Use, European Approval Decision Due This Year

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted two positive opinions for

09-19 18:48

被3000亿资金哄抢的创新药企，上市首日暴涨110%！

被3000亿资金哄抢的创新药企，上市首日暴涨110%！>>

09-19 16:44